Open Access. Powered by Scholars. Published by Universities.®
Pharmacy and Pharmaceutical Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 22 of 22
Full-Text Articles in Pharmacy and Pharmaceutical Sciences
Retrospective Review Of Anticoagulation Regimens Used For The Prevention Of Venous Thromboembolisms In Critically Ill Patients Infected With Sars-Cov-2, Tony Nguyen, Heidi Clarke
Retrospective Review Of Anticoagulation Regimens Used For The Prevention Of Venous Thromboembolisms In Critically Ill Patients Infected With Sars-Cov-2, Tony Nguyen, Heidi Clarke
All Publications
No abstract provided.
Impact Of Ketorolac On Opioid Consumption After Open Heart Surgery, Laura Neubauer, Radhan Gopalani, Kristen De Almeida, Andrea Marr-Peralto
Impact Of Ketorolac On Opioid Consumption After Open Heart Surgery, Laura Neubauer, Radhan Gopalani, Kristen De Almeida, Andrea Marr-Peralto
All Publications
No abstract provided.
Evaluation Of Albumin 5% Prescribing Patterns In Adult Hospitalized Patients, Robyn Feldman, Nicole Tadros, Heidi Clarke, Erika Dittmar
Evaluation Of Albumin 5% Prescribing Patterns In Adult Hospitalized Patients, Robyn Feldman, Nicole Tadros, Heidi Clarke, Erika Dittmar
All Publications
No abstract provided.
Evaluating The Association Between Vasopressin Use And In-Hospital Mortality In Patients With Septic Shock, Michael Pasqualicchio, Heidi Clarke, Jonathan Kline, Payal Patel
Evaluating The Association Between Vasopressin Use And In-Hospital Mortality In Patients With Septic Shock, Michael Pasqualicchio, Heidi Clarke, Jonathan Kline, Payal Patel
All Publications
No abstract provided.
Impact Of A Pharmacist-Driven Methicillin-Resistant Staphylococcus Aureus Nasal Swab Protocol On The De-Escalation Of Empiric Vancomycin In The Setting Of Community Acquired Pneumonia, Grether Hernandez Gama, Winifred Pardo, Wilbert Fuerte, James Adefisoye
Impact Of A Pharmacist-Driven Methicillin-Resistant Staphylococcus Aureus Nasal Swab Protocol On The De-Escalation Of Empiric Vancomycin In The Setting Of Community Acquired Pneumonia, Grether Hernandez Gama, Winifred Pardo, Wilbert Fuerte, James Adefisoye
All Publications
No abstract provided.
Effect Of Epoetin Alfa-Epbx Versus Epoetin Alfa On Hemoglobin Levels In Myelodysplastic Syndromes, Chemotherapy Induced Anemia, And Chronic Kidney Disease, Gabrielle Dubruille, Sigal Nadulek, Anderson Mabour
Effect Of Epoetin Alfa-Epbx Versus Epoetin Alfa On Hemoglobin Levels In Myelodysplastic Syndromes, Chemotherapy Induced Anemia, And Chronic Kidney Disease, Gabrielle Dubruille, Sigal Nadulek, Anderson Mabour
All Publications
No abstract provided.
Etomidate Use In Septic Patients Requiring Rapid Sequence Intubation, Elizabeth Osmon, Nishika Patel
Etomidate Use In Septic Patients Requiring Rapid Sequence Intubation, Elizabeth Osmon, Nishika Patel
All Publications
No abstract provided.
Risk Of Acute Kidney Injury In Patients Receiving Vancomycin And Piperacillin-Tazobactam Compared To Vancomycin And Cefepime, Viktoria Andonova
Risk Of Acute Kidney Injury In Patients Receiving Vancomycin And Piperacillin-Tazobactam Compared To Vancomycin And Cefepime, Viktoria Andonova
All Publications
No abstract provided.
Evaluating The Association Between Vasopressin Use And In-Hospital Mortality In Patients With Septic Shock, Michael Pasqualicchio, Heidi Clarke, Jonathan Kline, Payal Patel
Evaluating The Association Between Vasopressin Use And In-Hospital Mortality In Patients With Septic Shock, Michael Pasqualicchio, Heidi Clarke, Jonathan Kline, Payal Patel
All Publications
Purpose/Background: The Surviving Sepsis Campaign recommends norepinephrine as the first-line vasopressor in patients with septic shock to maintain a mean arterial pressure (MAP) of at least 65 mmHg. The guideline also makes a weak recommendation (2B) to use vasopressin as an adjuvant therapy to raise MAP to goal or to reduce the norepinephrine rate required to maintain the goal MAP. The recommendation is based on conflicting results of the VASST trial that showed no significant difference in 28-day all-cause mortality between patients managed with norepinephrine alone compared to norepinephrine and vasopressin. However, in subgroup analysis, the VASST trial showed mortality …
Transition From Fixed-Dosing To Symptom-Triggered Management Of Alcohol Withdrawal Syndrome In The Intensive Care Unit Of A Community Hospital, Marianela Robainas, Heidi Clarke, Claudia Chang, Frances Ordieres Gonzalez, Lorenzo Porras Jr.
Transition From Fixed-Dosing To Symptom-Triggered Management Of Alcohol Withdrawal Syndrome In The Intensive Care Unit Of A Community Hospital, Marianela Robainas, Heidi Clarke, Claudia Chang, Frances Ordieres Gonzalez, Lorenzo Porras Jr.
All Publications
Background/Purpose: In the United States, 2 to 7% of heavy alcohol users admitted to the hospital for general medical care will develop severe alcohol withdrawal (AW) requiring treatment. The most dangerous complications of AW are delirium tremens and seizures. Benzodiazepines (BZD) are considered first-line therapy, with varying modality options available to providers. Fixed-dosing has historically been used to manage AW. However, studies suggest that symptom-triggered therapy (STT) can decrease length of stay and BZD duration of therapy. The purpose of this study was to evaluate the current fixed-dose protocol and outline the transition to STT in the intensive care unit …
Calcitonin Prescribing Criteria For The Management Of Hypercalcemia In A Community Hospital, Jessica Hernandez, Radhan Gopalani, Heidi Clarke, Joyce Lee, Alyssa Donadio
Calcitonin Prescribing Criteria For The Management Of Hypercalcemia In A Community Hospital, Jessica Hernandez, Radhan Gopalani, Heidi Clarke, Joyce Lee, Alyssa Donadio
All Publications
Purpose/Background: Hypercalcemia is a clinical condition in which serum calcium levels exceed the upper limit of normal (>10.5 mg/dL). The most common causes of hypercalcemia are primary hyperparathyroidism and malignancy, however, it can also be caused by vitamin D intoxication, endocrine disorders, and immobilization due to an increase in bone resorption. First-line treatment of hypercalcemia includes hydration with intravenous (IV) normal saline and IV bisphosphonates. Calcitonin (Miacalcin®) is a synthetic hormone with a rapid onset of action and used intramuscularly (IM) or subcutaneously (SQ) as a second-line treatment in the management of hypercalcemia, specifically in severe and in symptomatic …
Review Of Adjunctive Midodrine To Facilitate Weaning Intravenous Vasopressors In Critically Ill Patients, Claudia Martin Diaz, Heidi Clarke, Payal Patel, Radhan Gopalani, Stephanie Palma
Review Of Adjunctive Midodrine To Facilitate Weaning Intravenous Vasopressors In Critically Ill Patients, Claudia Martin Diaz, Heidi Clarke, Payal Patel, Radhan Gopalani, Stephanie Palma
All Publications
Background/Purpose: Intravenous (IV) vasopressor agents are mainstay therapy for the management of refractory hypotension in critically ill patients in the intensive care unit (ICU). Patients remain in the ICU for vasopressor administration and monitoring which results in increased length of stay (LOS). Midodrine is an oral alpha-1 adrenergic agonist that causes vasoconstriction and increased blood pressure. It is commonly utilized off-label as an adjunctive therapy to help wean off vasopressors and decrease ICU LOS. Although midodrine offers many benefits, a study by Rizvi, et al stated that inappropriate continuation at hospital discharge resulted in a 1.6-fold higher risk of 1-year …
Pharmacological Prevention Of Atrial Fibrillation After Cardiac Surgery With And Without The Use Of Nonsteroidal Anti-Inflammatory Drugs, Laura Neubauer, Radhan Gopalani, Faaria Quadri, Mario Pascual, Heidi Clarke, Andrea Marr-Peralto
Pharmacological Prevention Of Atrial Fibrillation After Cardiac Surgery With And Without The Use Of Nonsteroidal Anti-Inflammatory Drugs, Laura Neubauer, Radhan Gopalani, Faaria Quadri, Mario Pascual, Heidi Clarke, Andrea Marr-Peralto
All Publications
Purpose: Atrial fibrillation after cardiac surgery (AFACS) is the most common complication following open heart procedures, with significantly increased morbidity and mortality associated with its occurrence1. A previous study done at Baptist Hospital of Miami (BHM) showed a decrease in the incidence of AFACS from 36% to 22% after implementation of a prevention protocol that includes guideline-directed therapy with a beta-blocker and amiodarone. The protocol also includes nonsteroidal anti-inflammatory drugs (NSAIDs) modeled after a study published in 2004 that showed that NSAIDs lowered the incidence of postoperative atrial fibrillation by 65% when they were used in the postoperative …
Evaluation Of Clinical Outcomes Of 4-Factor Prothrombin Complex Concentrate Versus Andexanet Alfa In The Treatment Of Intracerebral Hemorrhage, Eduardo Guizan Corrales, Radhan Gopalani, Heidi Clarke, Jonatha Kline, Felipe De Los Rios La Rosa, Thomas Wolfel
Evaluation Of Clinical Outcomes Of 4-Factor Prothrombin Complex Concentrate Versus Andexanet Alfa In The Treatment Of Intracerebral Hemorrhage, Eduardo Guizan Corrales, Radhan Gopalani, Heidi Clarke, Jonatha Kline, Felipe De Los Rios La Rosa, Thomas Wolfel
All Publications
Purpose: Oral anticoagulants account for up to 20% of intracerebral hemorrhages (ICH) with one-year mortality estimated as high as 54%. Several studies have examined the use of 4-Factor prothrombin complex concentrate (4F-PCC) and andexanet alfa in the treatment of factor Xa associated ICH. High cost burden, lack of clinical outcomes, and risk of thromboembolic events continues to be a major dilemma behind product selection at many healthcare systems. The purpose of this project is to compare clinical outcomes between 4F-PCC and andexanet alfa in the management of patients with ICH secondary to apixaban and rivaroxaban at Baptist Hospital of Miami …
Medical Marijuana High On Drug Interaction, Shahrzad Ghanavi
Medical Marijuana High On Drug Interaction, Shahrzad Ghanavi
All Publications
No abstract provided.
What A Blood Bath! Andexxa® Makes A Splash! Current Trends In Anticoagulation Reversal, Marianela Robainas
What A Blood Bath! Andexxa® Makes A Splash! Current Trends In Anticoagulation Reversal, Marianela Robainas
All Publications
No abstract provided.
Controlled Substance Validation, Claudia Martin Diaz, Jessica Hernandez, Laura Neubauer, Eduardo Guizan Corrales
Controlled Substance Validation, Claudia Martin Diaz, Jessica Hernandez, Laura Neubauer, Eduardo Guizan Corrales
All Publications
No abstract provided.
What A Blood Bath! Andexxa® Makes A Splash! Current Trends In Anticoagulation Reversal, Michael Pasqualicchio
What A Blood Bath! Andexxa® Makes A Splash! Current Trends In Anticoagulation Reversal, Michael Pasqualicchio
All Publications
No abstract provided.
Update On Oral Oncolytics: A Focus On Hematology Drugs, Monica Tadros
Update On Oral Oncolytics: A Focus On Hematology Drugs, Monica Tadros
All Publications
No abstract provided.
Oral Oncolytics, Gaines Kyna Gania
Precautions & Handling Of Hazardous Chemotherapeutic Agents, Paula Sayegh
Precautions & Handling Of Hazardous Chemotherapeutic Agents, Paula Sayegh
All Publications
No abstract provided.
Update On Oral Oncolytics, Elizabeth Osmon